The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Different Freezing Time in the Diffuse Parenchymal Lung Diseases
NCT ID: NCT03927235
Last Updated: 2019-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2019-05-16
2020-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Diseases
NCT03704233
The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in The Pulmonary Periphral Nodule
NCT04661956
The Comparison of Uniportal and Tubeless Video Assisted Thoracic Surgery and Transbronchial Lung Cryobiopsy in the Diagnosis of Interstitial Lung Disease
NCT03958162
Transbronchial Lung Cryobiopsy in Undiagnosed Acute Respiratory Failure
NCT05754866
A Retrospective Study of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis
NCT06275295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the freezing time of 3s
Transbronchial cryobiopsy in the freezing time of 3s
Transbronchial Cryobiopsy
Transbronchial Cryobiopsy in the Diagnosis of Diffuse Parenchymal Lung Diseases
the freezing time of 4s
Transbronchial cryobiopsy in the freezing time of 4s
Transbronchial Cryobiopsy
Transbronchial Cryobiopsy in the Diagnosis of Diffuse Parenchymal Lung Diseases
the freezing time of 5s
Transbronchial cryobiopsy in the freezing time of 5s
Transbronchial Cryobiopsy
Transbronchial Cryobiopsy in the Diagnosis of Diffuse Parenchymal Lung Diseases
the freezing time of 6s
Transbronchial cryobiopsy in the freezing time of 6s
Transbronchial Cryobiopsy
Transbronchial Cryobiopsy in the Diagnosis of Diffuse Parenchymal Lung Diseases
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transbronchial Cryobiopsy
Transbronchial Cryobiopsy in the Diagnosis of Diffuse Parenchymal Lung Diseases
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Transbronchial cryobiopsy(TBCB) is indicated by clinicians for definitive diagnosis and patients are content with the examination with agreement signed.
3. Blood gas analysis, routine blood test, ECG examination, coagulation function, immunological examination, chest HRCT, and liver/kidney function test have been completed.
Exclusion Criteria
2. The clinical examinations mentioned above are not completed.
3. The patient cannot endure or does not agree the procedure.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guangzhou Institute of Respiratory Disease
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ShiYue Li
Director of the Respiratory department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-3-30
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.